Stock Events

Eckert & Ziegler 

€46.08
101
-€3.58-7.21% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
947.64M
P/E Ratio
27.39
Dividend Yield
0.11%
Dividend
0.05

Upcoming

Dividends

0.11%Dividend Yield
10Y Growth
-22%
5Y Growth
-47.04%
3Y Growth
-51.93%
1Y Growth
-90%

Earnings

14MayConfirmed
Q4 2023
Q1 2024
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EUZ.XETRA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
ENDRA Life Sciences
NDRA
Mkt Cap6.42M
Endra Life Sciences develops technology for clinical diagnostic ultrasound, competing in the medical imaging sector similar to Eckert & Ziegler's radiopharma segment.
Intuitive Surgical
ISRG
Mkt Cap157.54B
Intuitive Surgical offers robotic-assisted surgical systems, indirectly competing with Eckert & Ziegler's medical equipment for cancer treatment.
Sensus Healthcare
SRTS
Mkt Cap101.14M
Sensus Healthcare focuses on non-invasive treatments for non-melanoma skin cancers and keloids, competing in the dermatology and oncology sectors.
Globus Medical
GMED
Mkt Cap8B
Globus Medical develops musculoskeletal solutions, indirectly competing with Eckert & Ziegler's products in the bone metastasis treatment market.
Boston Scientific
BSX
Mkt Cap114.22B
Boston Scientific Corporation offers medical devices for various health conditions, including cancer, competing in the broader medical device market.
Stryker
SYK
Mkt Cap129.28B
Stryker Corporation manufactures medical devices and equipment, including products for minimally invasive surgery, competing in the medical technology sector.
Medtronic
MDT
Mkt Cap99.95B
Medtronic plc provides medical technologies, services, and solutions, including cancer and chronic disease management, competing in the healthcare solutions sector.
Icad
ICAD
Mkt Cap34.5M
iCAD, Inc. offers image analysis, workflow solutions, and radiation therapy for early cancer detection and treatment, competing in the oncology and radiology sectors.
Zimmer Biomet
ZBH
Mkt Cap22.36B
Zimmer Biomet Holdings, Inc. manufactures orthopedic reconstructive products, indirectly competing with Eckert & Ziegler's offerings in the healthcare market.

About

Eckert & Ziegler SE, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, and other consumables. The Isotope Products segment manufactures and sells standard and radiation sources for medical and industrial sectors. This segment offers calibration related sources for radioisotopes. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is based in Berlin, Germany.
Show more...
CEO
Dr. Harald Hasselmann
Employees
1072
Country
DE
ISIN
DE0005659700
WKN
000565970

Listings